Your browser doesn't support javascript.
loading
PCSK9 inhibitors in clinical practice: Delivering on the promise?
Stoekenbroek, Robert M; Hartgers, Merel L; Rutte, Roger; de Wijer, Douwe D; Stroes, Erik S G; Hovingh, G Kees.
Affiliation
  • Stoekenbroek RM; Department of Vascular Medicine, Academic Medical Center, 1100DD Amsterdam, The Netherlands.
  • Hartgers ML; Department of Vascular Medicine, Academic Medical Center, 1100DD Amsterdam, The Netherlands.
  • Rutte R; Department of Vascular Medicine, Academic Medical Center, 1100DD Amsterdam, The Netherlands.
  • de Wijer DD; Department of Vascular Medicine, Academic Medical Center, 1100DD Amsterdam, The Netherlands.
  • Stroes ESG; Department of Vascular Medicine, Academic Medical Center, 1100DD Amsterdam, The Netherlands.
  • Hovingh GK; Department of Vascular Medicine, Academic Medical Center, 1100DD Amsterdam, The Netherlands. Electronic address: g.k.hovingh@amc.uva.nl.
Atherosclerosis ; 270: 205-210, 2018 03.
Article in En | MEDLINE | ID: mdl-29254691
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Serine Proteinase Inhibitors / PCSK9 Inhibitors / Hyperlipoproteinemia Type II / Cholesterol, LDL / Antibodies, Monoclonal / Anticholesteremic Agents Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Serine Proteinase Inhibitors / PCSK9 Inhibitors / Hyperlipoproteinemia Type II / Cholesterol, LDL / Antibodies, Monoclonal / Anticholesteremic Agents Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2018 Type: Article